Manulife Financial
MFCNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $44.24 Prior regular-session close from the quote source.
- $44.13–$44.68 Regular-session low and high so far today.
- 864.5K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $32.58–$46.19 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own MFC if Manulife turns insurance float and fee-bearing assets into steady cash flow and rising earnings; that cash — not accounting swings — is the engine that funds dividends, buybacks and organic growth.
MFC price history
Loading recent earnings…
Investment thesis
What must happen next
Manulife’s business will continue to convert underwriting and fee income into large, distributable operating cash flow because its asset base (float) and fee businesses generate stable investment spreads and recurring cash.StrengtheningMateriality: High
Operating cash flow rose year-over-year: CAD 20.423B (FY2023) -> CAD 26.494B (FY2024) -> CAD 32.105B (FY2025). If true, shareholders get rising dividends/buybacks and fewer equity raises; if false, the company will need to cut payouts or raise capital, hurting returns.
Watch: A sustained compression of investment spreads (e.g., prolonged low yields or large realized losses) that reduces cash generation before it shows in operating_cash_flow.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating cash flow rose year-over-year: CAD 20.423B (FY2023) -> CAD 26.494B (FY2024) -> CAD 32.105B (FY2025).
Open source ↗Growth in Manulife’s asset base (insurer float and AUM) will continue to allow revenue expansion because higher assets enable more premium originations, higher fee income and larger investment income.StrengtheningMateriality: High
Reported assets increased: CAD 875.574B (FY2023) -> CAD 978.818B (FY2024) -> CAD 1,025.433B (FY2025). Sustained asset growth supports revenue and future cash generation; if assets stop growing or shrink, top-line and investment income will follow and reduce capital for returns.
Watch: Significant persistent lapse rates or loss of distribution partners that cause premium runoff and AUM outflows.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Reported assets increased: CAD 875.574B (FY2023) -> CAD 978.818B (FY2024) -> CAD 1,025.433B (FY2025).
Open source ↗Manulife’s net income and EPS will remain positive and broadly rising because diversification across insurance, wealth fees and investments reduces one-off volatility and limits persistent losses.HoldingMateriality: Medium
Net income has been positive and increasing: CAD 5.607B (FY2023) -> CAD 5.878B (FY2024) -> CAD 6.060B (FY2025). Sustained positive net income underpins capital growth and shareholder returns; if earnings become volatile or negative, equity and dividends are at risk.
Watch: The company posted a large loss in FY2022 (CAD -1.979B), demonstrating that investment/underwriting shocks can produce negative earnings.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Net income has been positive and increasing: CAD 5.607B (FY2023) -> CAD 5.878B (FY2024) -> CAD 6.060B (FY2025).
Open source ↗Manulife’s book equity will remain sufficient to support ongoing buybacks and dividends because retained earnings and positive net income have broadly stabilized equity.StrengtheningMateriality: Medium
Equity increased from CAD 48.727B (FY2023) -> CAD 52.96B (FY2024) and remained ~CAD 52.488B in FY2025, indicating a stable capital base. If equity stays stable or grows, the company can return capital without risky leverage or dilution; if equity falls, dividends/buybacks may be cut or equity issued.
Watch: Regulatory capital requirement increases or an unexpected goodwill/asset impairment that reduces reported equity.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Equity increased from CAD 48.727B (FY2023) -> CAD 52.96B (FY2024) and remained ~CAD 52.488B in FY2025, indicating a stable capital.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Manulife’s business will continue to convert underwriting and fee income into large, distributable operating cash flow because its asset base (float) and fee businesses generate stable investment spreads and recurring cash. If true, shareholders get rising dividends/buybacks and fewer equity raises; if false, the company will need to cut payouts or raise capital, hurting returns.
Growth in Manulife’s asset base (insurer float and AUM) will continue to allow revenue expansion because higher assets enable more premium originations, higher fee income and larger investment income. Sustained asset growth supports revenue and future cash generation; if assets stop growing or shrink, top-line and investment income will follow and reduce capital for returns.
Manulife’s net income and EPS will remain positive and broadly rising because diversification across insurance, wealth fees and investments reduces one-off volatility and limits persistent losses. Sustained positive net income underpins capital growth and shareholder returns; if earnings become volatile or negative, equity and dividends are at risk.
Manulife’s book equity will remain sufficient to support ongoing buybacks and dividends because retained earnings and positive net income have broadly stabilized equity. If equity stays stable or grows, the company can return capital without risky leverage or dilution; if equity falls, dividends/buybacks may be cut or equity issued.
All standing thesis claims
Original report summary
Manulife turns insurance float and fee-bearing assets into steady cash flow and rising earnings; that cash — not accounting swings — is the engine that funds dividends, buybacks and organic growth.
Bull case and bear case
Bull case and bear case for Manulife Financial
Where the evidence on Manulife Financial stands: Holding on the latest evidence (Oct 26, 2026). Of its 4 thesis points, 3 strengthening and 1 holding.
Bull case: what the evidence supports
Manulife’s business will continue to convert underwriting and fee income into large, distributable operating cash flow because its asset base (float) and fee businesses generate stable investment spreads and recurring cash.
Growth in Manulife’s asset base (insurer float and AUM) will continue to allow revenue expansion because higher assets enable more premium originations, higher fee income and larger investment income.
Manulife’s net income and EPS will remain positive and broadly rising because diversification across insurance, wealth fees and investments reduces one-off volatility and limits persistent losses.
Manulife’s book equity will remain sufficient to support ongoing buybacks and dividends because retained earnings and positive net income have broadly stabilized equity.
Bear case: what would count against it
A sustained compression of investment spreads (e.g., prolonged low yields or large realized losses) that reduces cash generation before it shows in operating_cash_flow.
Significant persistent lapse rates or loss of distribution partners that cause premium runoff and AUM outflows.
The company posted a large loss in FY2022 (CAD -1.979B), demonstrating that investment/underwriting shocks can produce negative earnings.
Thesis-Break Engine
What has broken in Manulife Financial’s thesis
Each break OptimistFi flagged on Manulife Financial, dated — with what has historically followed the same kind of break across the market, not a forecast for Manulife Financial.
- Analyst downgradecondition set before this filing
Across all companies, this kind of break has happened 12,641 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedForeign issuer material report (6-K).
Manulife Financial filed an SEC report on 2026-09-11: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
Manulife Financial filed an SEC report on 2026-09-03: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
Manulife Financial filed an SEC report on 2026-09-02: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- A sustained compression of investment spreads (e.g., prolonged low yields or large realized losses) that reduces cash generation before it shows in operating_cash_flow.
- Significant persistent lapse rates or loss of distribution partners that cause premium runoff and AUM outflows.
- The company posted a large loss in FY2022 (CAD -1.979B), demonstrating that investment/underwriting shocks can produce negative earnings.
- Regulatory capital requirement increases or an unexpected goodwill/asset impairment that reduces reported equity.
MFC news
Loading headlines…
Financial statements
MFC income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
MFC: quick answers
- What is MFC's short interest?
- As of October 30, 2026, 12.8M MFC shares were sold short, up 41.4% from the count before. At the stock's average daily volume that is 9.3 days to cover. FINRA publishes the count twice a month. MFC short interest history
- Have members of Congress traded MFC?
- 15 trades in MFC have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed MFC trade
- Which well-known investors own MFC?
- 2 of the 37 well-known funds tracked here reported MFC shares in their latest 13F filings. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.1%; Maverick Capital, 0.0%. Fund portfolios
MFC in well-known investors’ portfolios
2 of 37 funds reported MFC shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Ray DalioBridgewater Associates | 0.11% | $27.8M | −67.6% | Q2 2026 |
| Maverick Capital | 0.01% | $1.1M | +17.7% | Q2 2026 |
